Longeveron Inc. current report, 15 March 2021

Business Context and Reporting Period

This Form 8-K filing by Longeveron Inc. (LGVN) reports on events occurring on March 15, 2021. The Company, an emerging growth company incorporated in Delaware, is reporting the partial exercise of an over-allotment option related to its initial public offering (IPO).

Key Financial Metrics

  • Shares Sold: 250,000 additional shares of Class A Common Stock sold under the over-allotment option.
  • Offering Price: $10.00 per share.
  • Total IPO Shares: 2,910,000 shares (including the initial 2,660,000 shares).
  • Total Net Proceeds: Approximately $27 million (after deducting underwriting discounts and estimated offering expenses).
  • Underwriting Commission: 7.0% on the over-allotment shares.

Material Changes

The primary material change is the increase in total capital raised and shares outstanding following the partial exercise of the 30-day over-allotment option granted to underwriters. The total number of shares sold in the IPO increased from 2,660,000 to 2,910,000.

Guidance, Outlook, and Risks

The filing does not provide specific financial guidance, future outlook, or management commentary beyond the transaction details. No specific risks or contingencies are detailed in this report other than the standard disclosure of the offering terms. The filing references a press release (Exhibit 99.1) for further details.

Investor Verification Checklist

  • Verify the final net proceeds of approximately $27 million against the Company's cash balance in subsequent filings.
  • Confirm the total share count of 2,910,000 issued in the IPO.
  • Review the full Underwriting Agreement to understand remaining obligations or conditions.
  • Check the referenced Press Release (Exhibit 99.1) for additional context on the use of proceeds.